Intel Market Research, the global Prostate Cancer PSMA-PET Imaging Agents market was valued at USD 1.12 billion in 2026 and is projected to reach USD 3.47 billion by 2034, growing at an impressive CAGR of 16.9% during the forecast period (2025-2034). This robust growth trajectory reflects the rising clinical adoption of precision diagnostic tools in prostate cancer management combined with significant technological advancements in radiopharmaceuticals.
The right load still has to suit the barrel. Twist matters for rimfire bullets, and barrel...
Ballistics charts look like a wall of numbers. Four columns carry most of the meaning, and...
Eight Mistakes Buyers Make With Mainstream Rifle Ammunition
A bullet only flies true if the barrel spins it fast enough. Here is how twist rate, bulle...